Dr. Parminder Sethi of Pacific Urology is recognized as an expert in treating benign prostatic hyperplasia (BPH), or enlarged prostate, with Rezūm®, a safe and effective minimally invasive treatment option for men suffering from BPH that provides an alternative to a lifetime of taking medications.
Dr. Sethi of Pacific Urology is one of the first Bay Area physicians trained in the Rezūm System, an innovative minimally invasive treatment option for men with benign prostatic hyperplasia (BPH).
Dr. Wei Zheng is featured in the June edition of the John Muir Health Physician Newsletter. Read his interview on kidney stone treatment and how to prevent them.
A new proposal by the U.S. Preventive Services Task Force is relaxing its controversial opposition to prostate-specific antigen (PSA) testing for men. PSA tests aid in the early detection of prostate cancer.
Pacific Urology is pleased to announce that Dr. Parminder Sethi has been selected by Castle Connolly as “America’s Top Doctors” for 2017. The notable recognition was recently featured in San Francisco Magazine.
Dr. Jeremy Lieb details the importance of new prostate cancer tests in a CNBC article.
Pacific Urology is a proud sponsor of a local Little League team – Dr. Lieb’s 2nd-grade son’s team, the Yankees!
In the 2016 edition of Urology Times, Dr. Long discusses the decline of men seeking PSA screenings and fewer referrals for elevated PSAs.
The San Francisco Magazine listed Dr. Parminder Sethi in their ‘Top Doctors of the Bay Area’ 2016 edition.
Summer poses a higher risk of heat-related dehydration—a condition caused by a lack of water in the body and one of the leading causes of kidney stones. John Muir Health, where many Pacific urology physicians practice, has enhanced their on-site kidney stone treatment with fixed site lithotripter for use when other therapies, including drinking lemonade, don’t work.